IL320962A - שיטות לטיפול בגידולים מוצקים מתקדמים - Google Patents

שיטות לטיפול בגידולים מוצקים מתקדמים

Info

Publication number
IL320962A
IL320962A IL320962A IL32096225A IL320962A IL 320962 A IL320962 A IL 320962A IL 320962 A IL320962 A IL 320962A IL 32096225 A IL32096225 A IL 32096225A IL 320962 A IL320962 A IL 320962A
Authority
IL
Israel
Prior art keywords
methods
solid tumors
advanced solid
treating advanced
treating
Prior art date
Application number
IL320962A
Other languages
English (en)
Inventor
Francis Burrows
Hernandez Amaya Gasco
Jovylyn Gatchalian
Victor S Gehling
Shivani Malik
Amitava Mitra
Harris Soifer
Original Assignee
Kura Oncology Inc
Francis Burrows
Hernandez Amaya Gasco
Jovylyn Gatchalian
Victor S Gehling
Shivani Malik
Amitava Mitra
Harris Soifer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kura Oncology Inc, Francis Burrows, Hernandez Amaya Gasco, Jovylyn Gatchalian, Victor S Gehling, Shivani Malik, Amitava Mitra, Harris Soifer filed Critical Kura Oncology Inc
Publication of IL320962A publication Critical patent/IL320962A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL320962A 2022-12-21 2025-05-17 שיטות לטיפול בגידולים מוצקים מתקדמים IL320962A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263476604P 2022-12-21 2022-12-21
US202363501108P 2023-05-09 2023-05-09
US202363582448P 2023-09-13 2023-09-13
PCT/US2023/085022 WO2024137751A1 (en) 2022-12-21 2023-12-20 Methods of treating advanced solid tumors

Publications (1)

Publication Number Publication Date
IL320962A true IL320962A (he) 2025-07-01

Family

ID=89771667

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320962A IL320962A (he) 2022-12-21 2025-05-17 שיטות לטיפול בגידולים מוצקים מתקדמים

Country Status (7)

Country Link
EP (1) EP4637769A1 (he)
JP (1) JP2025542187A (he)
KR (1) KR20250121542A (he)
CN (1) CN120282786A (he)
AU (1) AU2023409124A1 (he)
IL (1) IL320962A (he)
WO (1) WO2024137751A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024268271A1 (en) * 2023-05-09 2025-11-06 Kura Oncology, Inc. Methods of treating squamous cell carcinoma with a farnesyltransferase inhibitor and a pi3k inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1106612E (pt) * 1999-11-30 2004-06-30 Pfizer Prod Inc Derivados de quinolina uteis para inibir a farnesil-proteina-transferase

Also Published As

Publication number Publication date
EP4637769A1 (en) 2025-10-29
JP2025542187A (ja) 2025-12-25
KR20250121542A (ko) 2025-08-12
WO2024137751A1 (en) 2024-06-27
CN120282786A (zh) 2025-07-08
AU2023409124A1 (en) 2025-06-05

Similar Documents

Publication Publication Date Title
IL304275A (he) שיטות לטיפול בסרטן
IL312680A (he) שיטות לטיפול בסרטן
EP4153176A4 (en) METHODS OF TREATING CANCER
IL320332A (he) שיטות לטיפול בסרטן
IL319131A (he) שיטות לטיפול בגידולים מוצקים בעלי הפעלת שינויים בגן fgfr3
IL287210A (he) תכשירים לטיפול בגידולים
EP4111202A4 (en) CANCER TREATMENT METHODS
IL320962A (he) שיטות לטיפול בגידולים מוצקים מתקדמים
IL316829A (he) מעכבי מנין-mll לטיפול בסרטן
IL320743A (he) שיטה לטיפול בסרטן הערמונית
IL289811A (he) שיטה לטיפול בסרטן
IL325326A (he) שיטת טיפול בסרטן עם מעכבי אינדולין של kif18a
SG11202107017TA (en) Methods of treating cancer
IL319403A (he) הרכבים ושיטות לטיפול בגידולים מוצקים מתקדמים
CA3275109A1 (en) Methods of treating advanced solid tumors
IL312155A (he) שיטה לטיפול בסרטן
IL272390A (he) שיטות לטיפול בסרטן
EP4504800A4 (en) Treatment of solid tumors
IL315569A (he) שיטות לטיפול בסרטן
HK40076175A (en) Methods of treating tumors
IL312332A (he) שיטות לטיפול בסרטן
IL320448A (he) שיטות לטיפול בסרטן באמצעות סוטורסיב
IL320471A (he) שיטות לטיפול בסרטן המבטא dll3
IL315674A (he) תרכובות ושיטות לטיפול בסרטן
IL314798A (he) שיטות לטיפול בסרטן הערמונית